Intriguingly, it has been shown that enhanced expression of Cisd2 can decrease the levels of liver triglyceride and lipid peroxidation in the liver of HBx transgenic mice and attenuate the development of HBV-associated HCC [16]. Here, CISD2 is linked to hepatocellular carcinoma.